期刊文献+

3-脱氧葡萄糖醛酮代谢酶研究进展

Advances of 3-deoxyglucosone metabolizing enzymes
下载PDF
导出
摘要 3-脱氧葡糖醛酮(3-Deoxyglucosone,3-DG)是一种高反应性的毒性2-羰基醛化合物,在3-DG还原酶作用下可脱毒生成3-脱氧果糖,在羰基醛脱氢酶作用下脱毒生成3-脱氧葡萄糖醛酸。3-DG代谢酶系统作为一种自身防御系统,可能通过调节3-DG而减少美拉德反应的进行和晚期糖基化终末产物(Advanced glycation end products,AGEs)过量生成,并使3-DG处于相对正常水平,这对防止老化病、糖尿病、尿毒症等方面均有积极意义。本文对3-DG代谢酶的来源、分布情况,酶的种类、部分酶学性质及其与临床疾病的关系等研究进展做简要综述。 3-deoxyglucosone(3-DG) ,a highly reactive and cytotoxic 2-oxoaldehyde compound,is detoxified mainly to 3-deoxyfructose by 3-DG- reducing enzymes, or to 2-keto-3-deoxygluconic acid by oxoaldehyde dehydrogenase. 3-DG metabolizing enzymes, self-defence enzymes, may keep the concentrations of 3-DG at normal level by adjusting the reactive 2-oxoaldehyde compounds like 3-DG,preventing the advanced stage of the Maillard reaction and inhibiting the overproduction of advanced glycation end products (AGEs). These evidences suggest that 3-DG metabolizing enzymes have played an active role in preventing the development of aging,diabetes and uremia. This paper reviews the sources ,distribution,kinds,enzymatic character of 3-DG metabolizing enzymes and their relationship with clinical diseases associated with 3-DG.
出处 《安徽医药》 CAS 2008年第12期1128-1131,共4页 Anhui Medical and Pharmaceutical Journal
基金 江苏省中医药管理局科研课题资助项目
关键词 3-脱氧葡萄糖醛酮代谢酶 3-脱氧葡萄糖醛酮 综述 美拉德反应 3-deoxyglucosone metabolizing enzymes 3-deoxyglucosone review
  • 相关文献

参考文献29

  • 1Tsukushi S, Katsuzaki T, Aoyama I, et al. Increased erythrocyte 3- DG and AGE in diabetic hemodialysis patients : role of the polyol pathway [ J ]. Kidney Int, 1999,55 : 1970 - 6.
  • 2Okado A, Kawasaki Y, Hasuike Y, et al. Induction of apoptotic cell death by methylglyoxal and 3-deoxyglucosone in macrophage-defived cell lines [ J ]. Biochemical and biophysical research communica- tion, 1996,225 ( 1 ) :219 - 24.
  • 3Park YS, Koh YH, Takahashi M, et al. Identification of the binding site of methylglyoxal on glutathione peroxidase: methylglyoxal inhibits glutathione peroxidase activity via binding to glutathione binding sites Arg 184 and 185 [J]. Free Radic Res,2003,37(2):205 -11.
  • 4Sakiyama H, Takahashi M, Yamamoto T, et al. The internalization and metabolism of 3-Deoxyglucosone in human umbilical vein endothelial cells [ J]. J Biocbem,2006,139:245 - 53.
  • 5Supplement to American Academy of Dermatology 66th Annual Meeting. Inhibitors of 3-deoxyglucosone (3DG) treat aging and inflamed skin by preventing the formation of AGEs, oxidative stress, and free radicals [ S ]. San Antonio, Texas: J AM ACAD DERMATOL,2008:231.
  • 6Kusunoki H, Miyata S, Ohara T, et al. Relation between serum 3-DG and development of diabetic mieroangiopathy [ J ]. Diabetes care, 2003,26 (6) : 1889 - 94.
  • 7Niwa T, Takeda N, Miyazaki T, et al. Elevated serum levels of 3-deoxyglucosone, a potent protein-cross-linking intermediate of the Maillard reaction, in uremic patients [ J]. Nephron, 1995,69:433 - 8.
  • 8Niwa T, Katsuzaki T, Momoi T, et al. Modification of β2m with advanced glycation end products as observed in dialysis-related amyloidosis by 3-DG accumulating in uremic serum [ J ]. Kidney Int, 1996,49:861 - 7.
  • 9Verzijl N, DeGroot J, Oldehinkel E, et al. Age-related accumulation of Maillard reaction products in human articular cartilage collagen [ J]. Biochem J ,2000,350:381 - 7.
  • 10关荣发,刘东红,叶兴乾,杨开.Use of fluorometry for determination of skim milk powder adulteration in fresh milk[J].Journal of Zhejiang University-Science B(Biomedicine & Biotechnology),2005,6(11):1101-1106. 被引量:5

二级参考文献16

共引文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部